Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
Roman Tyzio(Inserm), Yehezkel Ben‐Ari(Neurochlore (France)), Ilgam Khalilov(Inserm), Corinne Brouchoud(Inserm), Nail Burnashev(Inserm), Romain Nardou(Neurochlore (France)), Timur Tsintsadze(Inserm), Diana C. Ferrari(Neurochlore (France)), Amene Shahrokhi(Neurochlore (France)), Sanaz Eftekhari(Neurochlore (France)), Geneviève Chazal(Inserm), Éric Lemonnier(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Natalia Lozovaya(Inserm), Vera Tsintsadze(Inserm)
Cited by 587
Related Papers
X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family
|The American Journal of Human Genetics|2004|762
A randomised controlled trial of bumetanide in the treatment of autism in children
|Translational Psychiatry|2012|310
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
|Translational Psychiatry|2017|210
The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects
|Acta Paediatrica|2010|142
Emotional contagion for pain is intact in autism spectrum disorders
|Translational Psychiatry|2014|139